Skip to main content

Table 1 Summary of miRNA expression studies on samples from prostate cancer patients

From: miRNAs associated with prostate cancer risk and progression

Author year (reference) Tissue/serum Outcome miRNA identified
Risk/Diagnostic
 Ozen, 2008 [79] Tissue Risk/Diagnostic Let-7b-g, 26a-b, 29a-c, 30a-e, 99a-b, 125a-b
 Gandellini, 2009 [78] Tissue Risk/Diagnostic miR-205
 Mahn 2011 [118] Tissue/Serum Diagnostic let7i, 16, 26a, 195
 Wach, 2012 [10] Tissue Diagnostic miR-143, 145, 375
 Avgeris, 2013 [101] Tissue Diagnostic miR-145
 Srivastava, 2013 [105] Tissue/Urine Diagnostic miR-205, 221, 99b
 Tsuchiyama, 2013 [106] Tissue Diagnostic miR-182-5p
 Guzel 2015 [107] Tissue Diagnostic miR-361-3p, 133b, 221, 203
 Roberts, 2015 [128] Tissue/Serum Diagnostic miR-200b, 200c, 375
 Kristensen 2016 [112] Tissue Diagnostic Up: miR-375, 663b, 615-3p, 425-5p, 663a, 182-5p, 183-5p.
Down: miR-205-5p, 221-3p, 222-3p, 376c-3p, 136-5p, 455-3p, 455-5p, −154-5p
 Mitchell, 2008 [35] Serum Diagnostic miR-141
 Lodes, 2009 [137] Serum Diagnostic miR-16, 92a, 103, 107
 Moltzahn, 2011 [99] Serum Diagnostic miR-26b, 223, 874, 1274a
 Yaman Agaoglu, 2011 [54] Plasma Diagnostic miR-21, 141, 221
 Selth, 2012 [114] Serum Diagnostic miR-141, 298, 346, 375
 Chen 2012 [119] Plasma Diagnostic let7c, let7e, 30c, 622, 1285
 Cheng, 2013 [120] Serum Diagnostic miR-210
 Haldrup, 2014 [113] Serum Diagnostic miR-141, 375
 Westermann, 2014 [121] Serum Diagnostic miR-141
 Kachakova, 2015 [122] Plasma Diagnostic let-7c, 375
 Haj-Ahmad, 2014 [126] Urine Diagnostic miR-182-5, 484
 Korzeniewski, 2014 [127] Urine Diagnostic miR-483-5p, 1275, 1290
Risk/Progression
 Porkka, 2007 [87] Tissue Risk/Progression Let-7a-d, Let-7f, 19b, 145, 184, 198, 202, 210,
 Ambs, 2008 [40] Tissue Risk/Progression miR-1, 32, 101, 106b, 182, 200a, 200b, 494, 520 h
 Mercatelli, 2008 [42] Tissue Progression miR-221, 222
 Prueitt, 2008 [80] Tissue Progression miR-2, 10, 125b, 224
 Tong, 2009 [76] Tissue Risk/Progression miR-23b, 100, 135b, 145, 194, 221, 222
 Wang, 2009 [90] Tissue Progression miR-9*, 16, 221, 222, 331-3p, 145, 551a
 Szczyrba, 2010 [61] Tissue Progression miR-143
 Shaefer, 2010 [81] Tissue Risk/Progression miR-96, 205
 Pesta, 2010 [93] Tissue Progression miR-20a
 Khan, 2010 [88] Tissue Progression miR-128
 Spahn, 2010 [91] Tissue Progression miR-221
 Hagman, 2010 [92] Tissue Risk/Progression miR-34c
 Brase, 2011 [115] Tissue/Serum Progression miR-141, 375
 Barnabas, 2011 [103] Tissue Progression miR-151
 Leite, 2011 [138] Tissue Progression let7c, miR-100, miR-145, miR-191
 Martens-Uzunova, 2012 [48] Tissue Progression miR-1, 133a, 133b, 143, 143*, 145, 145*, 204, 221, 222
 Li, 2012 [55] Tissue Progression miR-21
 Tsuchiyama, 2013 [106] Tissue Progression miR-182-5p
 Amankwah, 2013 [102] Tissue Progression miR-21
 He, 2013 [134] Tissue Progression miR-19a, miR-374b
 Kristensen, 2014 [89] Tissue Progression miR-224, 452
 Wang, 2014 [124] Tissue/Serum Progression miR-19, miR-345, miR-519c-5p
 Dip, 2015 [139] Tissue Progression Let-7c
 Zhang, 2011 [100] Serum Progression miR-21
 Yaman Agaoglu, 2011 [54] Plasma Progression miR-21, miR-221
 Shen, 2012 [56] Plasma Progression miR-20a, miR-21, miR-145, miR-221
 Watahiki, 2013 [123] Plasma Progression miR-21, −126, −141, −151-3p, −152, −200c,-375, −423-3p
 Nguyen, 2013 [116] Serum Progression miR-141, miR-375, miR-378, miR-409-3p
Diagnostic/Progression
 Hao, 2011 [95] Tissue Diagnostic/Progression miR-21
 Mihelich, 2011 [98] Tissue Diagnostic/Progression miR-96, miR-182, miR-183
 Bryant 2012 [117] Serum/Urine Diagnostic/Progression miR-181a-2, miR-625, miR-107, miR-574-3p, miR-20a, miR-23a, miR-624
 Mavridis, 2013 [109] Tissue Diagnostic/Progression miR-224
 Larne, 2013 [108] Tissue Diagnostic/Progression miR-96-5p, miR-183-5p, miR-145-5p, miR-221-5p
 Walter, 2013 [110] Tissue Diagnostic/Progression Up: miR-122, miR-335, miR-184, miR-193, miR-34, miR-138,
Down: miR-373, −9, −198, −144 -215, −96, −222, −148, −92, −27, −125, −126, −27
 Casanova-Salas, 2014 [111] Tissue/Serum Diagnostic/Progression miR-187 and miR-182
 Mihelich, 2015 [125] Serum Diagnostic/Progression let-7a, −24, −26b, −30c, −93, −100, −103, −106a, −107, −130b, −146a, −223, −451, −874,
 Kristensen, 2016 [112] Tissue Diagnostic/Progression miR185-5p, miR-221-3p, miR-326
Treatment response
 He, 2013 [134] Tissue Treatment Response miR-23b, miR-220, miR-221, miR-222, and miR-205
 Lichner, 2013 [135] Tissue Treatment Response miR-152
 Gonzales, 2011 [133] Plasma Treatment Response miR-141
 Cheng, 2013 [120] Serum Treatment Response miR-210
 Someya, 2015 [136] Blood Treatment Response miR-99a